About Us

Archives






Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer

Posted: October 5, 2021 at 6:08 pm


NEW YORK and SCOTTSDALE, Ariz., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”) focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products, today announces the appointment of Ernest De Paolantonio as Chief Financial Officer, effective September 30, 2021.

View original post here:
Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.